These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3170069)

  • 1. Activation of the alternative pathway of complement by larval Taenia taeniaeformis in resistant and susceptible strains of mice.
    Davis SW; Hammerberg B
    Int J Parasitol; 1988 Jul; 18(5):591-7. PubMed ID: 3170069
    [No Abstract]   [Full Text] [Related]  

  • 2. Taenia taeniaeformis: evasion of complement-mediated lysis by early larval stages following activation of the alternative pathway.
    Davis SW; Hammerberg B
    Int J Parasitol; 1990 Aug; 20(5):587-93. PubMed ID: 2228422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taenia taeniaeformis: early inflammatory response around developing metacestodes in the liver of resistant and susceptible mice I. Identification of leukocyte response with monoclonal antibodies.
    Letonja T; Hammerberg C
    J Parasitol; 1987 Oct; 73(5):962-70. PubMed ID: 3309243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance between Taenia taeniaeformis and Hymenolepis nana infections in C3H/He mice.
    Ito A; Bøgh H; Lightowlers MW; Rickard MD
    Int J Parasitol; 1988 Jul; 18(5):691-4. PubMed ID: 3170077
    [No Abstract]   [Full Text] [Related]  

  • 5. Taenia taeniaeformis: immunoprecipitation analysis of the protein antigens of oncospheres and larvae.
    Bowtell DD; Mitchell GF; Anders RF; Lightowlers MW; Rickard MD
    Exp Parasitol; 1983 Dec; 56(3):416-27. PubMed ID: 6641898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary observations on the clinical application of Cysticercus bovis polyphenylethylene gumastic agglutination test (author's transl)].
    Csao WJ
    Zhonghua Nei Ke Za Zhi; 1979; 18(2):124-7. PubMed ID: 555901
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of Cysticercus cellulosae antigens in the immunodiagnosis of human cysticercosis by ELISA].
    Chen JP; Zhang XY; Liu MF; Xiong J; Feng ML; Hu RY; Liu GL; Zhong HL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(1):32-5. PubMed ID: 3383391
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-GK1 antibodies damage Taenia crassiceps cysticerci through complement activation.
    Núñez G; Villalobos N; Herrera CP; Navarrete-Perea J; Méndez A; Martinez-Maya JJ; Bobes RJ; Fragoso G; Sciutto E; Aguilar L; Del Arenal IP
    Parasitol Res; 2018 Aug; 117(8):2543-2553. PubMed ID: 29876861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further observations on the nature and characteristics of cross protection against Fasciola hepatica produced in sheep by infection with Cysticercus tenuicollis.
    Dineen JK; Kelly JD; Campbell NJ
    Int J Parasitol; 1978 Jun; 8(3):173-6. PubMed ID: 748207
    [No Abstract]   [Full Text] [Related]  

  • 10. Levamisole--biological response modifier in Taenia crassiceps--mouse experimental system.
    Lukes S
    Folia Parasitol (Praha); 1988; 35(1):37-40. PubMed ID: 3417199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inmunity in mice to an oncosphere infection by using oncospheral antigens from Taenia solium or Taeniarhynchus saginatus.
    Molinari JL; Tato P; Aguilar T; Palet A
    Rev Latinoam Microbiol; 1988; 30(4):325-33. PubMed ID: 3244925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and immunobiological studies of cysticercosis in cattle].
    Bankov N; Khadzhiiski D; Petrova S
    Vet Med Nauki; 1974; 11(3):22-8. PubMed ID: 4138637
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunisation of mice against Taenia taeniaeformis using antigens prepared from T. pisiformis and T. hydatigena eggs or oncospheres.
    Rickard MD; Rajasekariah GR; Mitchell GF
    Z Parasitenkd; 1981; 66(1):49-56. PubMed ID: 7324541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of a technic for detection of soluble antigens of Cysticercus cellulosae].
    Velasco O; Guzmán Bracho C; Gutiérrez Quiroz M; Romero V; Pulido RM
    Salud Publica Mex; 1983; 25(2):205-8. PubMed ID: 6879329
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis.
    Alonso-Trujillo J; Rivera-Montoya I; Rodríguez-Sosa M; Terrazas LI
    Parasitol Res; 2007 May; 100(6):1341-50. PubMed ID: 17206501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taenia crassiceps cysticercosis: immune response in susceptible and resistant BALB/c mouse substrains.
    López-Briones S; Lamoyi E; Fragoso G; Soloski MJ; Sciutto E
    Parasitol Res; 2003 Jun; 90(3):236-42. PubMed ID: 12783314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydatidosis/cysticercosis: immune mechanisms and immunization against infection.
    Rickard MD; Williams JF
    Adv Parasitol; 1982; 21():229-96. PubMed ID: 6187188
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of an antigenic fraction of Cysticercus cellulosae in the serodiagnosis of cysticercosis.
    Pammenter MD; Rossouw EJ
    Ann Trop Med Parasitol; 1987 Apr; 81(2):117-23. PubMed ID: 2446571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the results of IFAT-DASS and ELISA tests in experimental cysticercosis of mice.
    Vánová L; Lukes S
    Folia Parasitol (Praha); 1987; 34(1):25-9. PubMed ID: 3556351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of host immune response in the occurrence of gastropathy in rats infected with larval Taenia taeniaeformis.
    Abella JA; Oku Y; Nonaka N; Ito M; Kamiya M
    J Vet Med Sci; 1997 Nov; 59(11):1039-43. PubMed ID: 9409522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.